Subscribe
denis-simonov
Denis Simonov / Shutterstock.com
18 June 2020Americas

MicroPort accuses rival of selling ‘knock-off’ surgical tools

MicroPort Orthopedics has sued rival  Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
Rouse and Codex launch new China partnership
4 June 2020   IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.
Europe
Teva to face inhaler infringement allegations in UK court
3 June 2020   Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.


Editor's picks

A step too far? Why Stewart’s approach is dividing opinion
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

Editor's picks

Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

More on this story

Asia
Rouse and Codex launch new China partnership
4 June 2020   IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.
Europe
Teva to face inhaler infringement allegations in UK court
3 June 2020   Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.

More on this story

Asia
Rouse and Codex launch new China partnership
4 June 2020   IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.
Europe
Teva to face inhaler infringement allegations in UK court
3 June 2020   Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.

More features

Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?
Broad Institute wins appeal to restore CRISPR patent in Europe
BMS faces fresh lawsuit over alleged cancer drug monopoly
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations
Boies Schiller Flexner adds three-strong litigation team